Patent 9950058 was granted and assigned to Pfizer Limited on April, 2018 by the United States Patent and Trademark Office.
The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.